Points to Consider on the Use of Medicines in Pregnancy Throughout the Product Lifecycle Based on Global Regulatory Guidance.
- DOI
- 10.1007/s43441-024-00736-0
- Published
- 2025 May
- Container
- Therapeutic innovation & regulatory science
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s43441-024-00736-0,
title = {Points to Consider on the Use of Medicines in Pregnancy Throughout the Product Lifecycle Based on Global Regulatory Guidance.},
author = {Alexe A and Wurst K and Balramsingh-Harry L and Apara O and Abramova N and Eisele O and Fernandes MFS and Garg A and Kovacs B and Lewis D},
year = {2025},
journal = {Therapeutic innovation \& regulatory science},
doi = {10.1007/s43441-024-00736-0},
url = {https://doi.org/10.1007/s43441-024-00736-0}
}RIS
TY - JOUR TI - Points to Consider on the Use of Medicines in Pregnancy Throughout the Product Lifecycle Based on Global Regulatory Guidance. AU - Alexe A AU - Wurst K AU - Balramsingh-Harry L AU - Apara O AU - Abramova N AU - Eisele O AU - Fernandes MFS AU - Garg A AU - Kovacs B AU - Lewis D PY - 2025 JO - Therapeutic innovation & regulatory science DO - 10.1007/s43441-024-00736-0 UR - https://doi.org/10.1007/s43441-024-00736-0 ER -
APA
A, A., K, W., L, B., O, A., N, A., O, E., MFS, F., A, G., B, K., & D, L. (2025). Points to Consider on the Use of Medicines in Pregnancy Throughout the Product Lifecycle Based on Global Regulatory Guidance.. Therapeutic innovation & regulatory science. https://doi.org/10.1007/s43441-024-00736-0
Source records
- pubmed · retrieved 2026-09-27T14:30:55.300Z